Insiders who reported open-market trades in the last 12 months at the companies Timothy T. Richards files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Joseph Burnett - $2.16M in CLPT purchases and sales in the last 12 months
Matthew B. Klein - $185K in CLPT purchases and sales in the last 12 months
Lynnette C. Fallon - $57K in CLPT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Timothy T. Richards is a corporate insider, tracked as Director of ClearPoint Neuro, Inc. (CLPT). InsiderAlpha holds 15 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Timothy T. Richards submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Timothy T. Richards been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($199K) across all tracked filings.
Timothy T. Richards is Director of ClearPoint Neuro, Inc. (CLPT). 15 SEC Form 4 filings on record going back to 2024, most recently on 2 October 2026. Most recent open-market trade: sold $66K of CLPT on 2 June 2026. Lifetime open-market sales: $199K.
Recent transactions
14
The latest 14 SEC Form 4 transactions reported by Timothy T. Richards.
InsiderAlpha's records for Timothy T. Richards go back to 2024: 15 primary Form 4 filings, an average of 5.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
